Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Nutr Metab Cardiovasc Dis. 2022 May 31;32(8):1998–2009. doi: 10.1016/j.numecd.2022.05.018

Table 2.

Changes to blood pressure, as measured on-site by the health contractor.

Site 1 Site 2 Total

Systolic BP Baseline, mmHg
 Mean ± SD 137.62 ± 20.5 138.15 ± 16.97 137.87 ± 18.8
 (Range), n (98, 191) n = 45 (101, 175) n = 39 (98, 191) n = 84
Systolic BP Month 1, mmHg
 Mean ± SD 135.29 ± 17.09 129.65 ± 16.24 133.44 ± 16.9
 (Range), n (98, 191) n = 41 (100, 156) n = 20 (98, 191) n = 61
Primary Outcome Month 1 – Baseline, mmHg
 Mean Change ± SD −2.66b ± 19.56 −8.0 ± 16.9 −4.41 ± 18.76
t = −0.87, p = 0.39 t = −2.12, p = 0.048 t = −1.84, p = 0.07
n = 41 n = 20 n = 61
Systolic BP Month 3, mmHg
 Mean ± SD 134.48 ± 14.09
 (Range), n (105, 165), n = 33
Month 3-Baseline, mmHg
 Mean Change ± SD −3.51 ± 17.2
t = −1.17, p = 0.25
n = 33
Controlleda BP, Baseline 71.1% 64.1% 67.9%
Controlleda BP, Month 1 80.5% (χ2 = 2.67, p = 0.10) 90% (χ2 = 0.33, p = 0.56) 83.6% (χ2 = 2.78, p = 0.10)
Controlleda BP, Month 3 81.8% (χ2 = 1.90, p = 0.17)
a

As defined by JNC-8 Guidelines (32).

b

Bold items reflect the primary outcomes and associated measures of their significance.